Header Logo

Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus.

Jarvis CI, Cabrera A, Charron D. Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus. Ann Pharmacother. 2013 Nov; 47(11):1532-9.

View in: PubMed